This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version    RSS    Subscribe    Unsubscribe    Archive    Media Kit May. 30, 2013

Home   About ITNS   Members Only   Membership   Education   Store   Careers   Research   Support   Contact Us  



Prevent Hazardous Drug Exposure

PhaSeal has been the only clinically proven closed-system drug transfer device for the safe handling of hazardous drugs.

 


Dying girl's plight sparks fight over organ transplants
CNN
The plight of a 10-year-old Pennsylvania girl who could die within weeks without a lung transplant has sparked a fight for new rules governing organ donations. Tens of thousands of people have signed a petition on Change.org, and a congressman has called on the Obama administration to take quick action.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


ASSOCIATION NEWS


2013 Transplant Nursing Excellence Award
The International Transplant Nurses Society recognizes that the role of the transplant nurse is unique and dealing with patients through the transplant continuum is often complex and challenging. ITNS wishes to recognize a special nurse whose career has exemplified the mission of ITNS: "...promotion of excellence in transplant clinical nursing through the provision of educational and professional growth opportunities, interdisciplinary networking, collaborative activities and transplant nursing research."

The Transplant Nursing Excellence Award is offered yearly and presented at the Annual Symposium, held this year from Sept. 21-23 in Washington, D.C.

Submit a nomination today! All nominations must be received by Aug. 9.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




Product Feature
Introduction to Transplant Nursing Core Competencies

This book is specifically for nurses working in the area of transplantation. Fifteen domains of practice are identified and within each domain, competencies for the three primary nursing roles (Transplant Nurses, Transplant Nurse Coordinator, and Advanced Practice Transplant Nurse) are delineated. ITNS members receive a special discount on this publication. Purchase your copy today!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


ITNS Chapters
Email your chapter events to abegezda@itns.org to get it listed on the ITNS calendar. This is a free membership benefit and a great way to promote chapter events!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




Looking to share your expertise?
MultiBriefs
In an effort to enhance the overall content of the ITNS Insider, we'd like to include peer-written articles in future editions. As a member of ITNS, your knowledge of the industry lends itself to unprecedented expertise. And we're hoping you'll share this expertise with your peers through well-written commentary. Because of the digital format, there's no word or graphical limit and our group of talented editors can help with final edits. If you're interested in participating, please contact Ronnie Richard to discuss logistics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


INDUSTRY NEWS


Short disease duration, worsening IBD linked after liver transplantation
Healio
Liver transplant recipients with IBD are more likely to experience worsening disease posttransplant with shorter disease duration, according to data presented at Digestive Disease Week. Researchers performed a retrospective chart analysis of 924 patients who underwent liver transplantation between 1998 and 2012. The cohort included 45 patients with posttransplant IBD, including 38 with previous IBD and seven who developed de novo IBD after the procedure. IBD severity was determined according to symptoms, complications, hospitalizations because of flares and use of steroids or immunosuppressive medications.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies
NCBI
In the U.S., more than 2600 kidneys are discarded annually, from the total number of kidneys procured for transplant. It has been hypothesized that this organ pool may be used as a platform for renal bioengineering and regeneration research. The purpose of the current study was to test if the same strategy can be applied to discarded human kidneys in order to obtain human renal ECM scaffolds. The results show that the sodium dodecylsulfate-based decellularization protocol completely cleared the cellular compartment in these kidneys, while the innate ECM framework retained its architecture and biochemical properties.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Nurses want 'healthcare versions' of user-friendly personal apps
MedCity News
Nurses are the unsung heroes of the hospital who navigate crappy software on outdated hardware to keep you healthy — and it needs to stop. Technology innovators need to start focusing on new, consumer-like user experiences and better end-to-end communications software and hardware. Otherwise, nurses are going to start using their own devices, which creates obvious issues in privacy and data management.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Rejection of medical implants could be prevented by synthetic biomaterial
Science World Report
Medical implants and devices can be life saving or health restoring, but our body doesn't automatically know that and sometimes rejects these foreign objects, a natural response with problematic consequences. But as usual, our body can be tricked with the right kind of material to keep quiet. University of Washington engineers have demonstrated a synthetic biomaterial that does just that, as tested in mice where it prevented a negative response to foreign objects coated with it.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Living donor size affects kidney transplant outcomes
Renal & Urology News
Small donor size has an adverse impact on allograft function following living kidney donor transplantation, researchers reported at the 2013 American Transplant Congress. Dr. Hasan Khamash and colleagues at Mayo Clinic Arizona in Phoenix retrospectively studied 579 pairs of living kidney donors and recipients who had their estimated glomerular filtration rate ascertained at one year posttransplant.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Higher patient satisfaction is determined by nurses
Health Leaders Media
Because higher patient satisfaction scores translate to higher Medicare reimbursements, how nurses interact and talk with patients has a demonstrable and significant impact on a hospital's bottom line.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Health inspectors want tougher checks on medical implants
Dutch News
Checks on the safety of medical implants such as artificial hips fall far short of optimal and doctors should be required by law to report all incidents to the factories, the Dutch health inspectorate said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Doctors use 3-D printer to custom-design implant for baby
USA Today
Researchers at the University of Michigan have used a 3-D printer to create a custom-made, life-saving implant for baby boy, they report in a letter in The New England Journal of Medicine. The baby, Kaiba Gionfriddo, suffered from a rare disorder in which one of the airways in his lungs collapsed when he exhaled. The problem caused him to stop breathing and turn blue when he was only 6 weeks old. Even with a mechanical ventilator, Kaiba stopped breathing virtually every day, requiring doctors to perform emergency resuscitations.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Trial: Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients
Clinical Transplantation
In a recent clinical trial, researchers compared in kidney transplantation two immunosuppressive regimens: Tacrolimus plus mycophenolate mofetil and everolimus plus low-dose cyclosporine. Sixty consecutive patients received TAC (30 patients) or EVE (30 patients) as immunosuppressive regimen; all subjects also received induction with basiliximab and corticosteroids. After a three-year follow-up, no difference was found in patient and graft survival.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ITNS Insider

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Brie Ragland, Content Editor, 469.420.2639  
Contribute news


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the ITNS Insider was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

May 30, 2013
May 23, 2013
May 16, 2013
May 9, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063